Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–14 of 14 trials
Active filters
Clinical trials found
Published and searchable clinical trials
NCT07357727
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Summit Medical Group Oncology Berkeley Heights, New Jersey, United States
- The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
- Novartis Investigative Site Buenos Aires, Buenos Aires F.D., Argentina
- Novartis Investigative Site Capital Federal, Argentina
NCT07340138
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Novartis Investigative Site Kamogawa, Chiba, Japan
- Novartis Investigative Site Sapporo, Hokkaido, Japan
- Novartis Investigative Site Kamakura, Kanagawa, Japan
- Novartis Investigative Site Kurashiki, Okayama-ken, Japan
NCT07469891
- Conditions
- Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +13 more
- Locations
-
- Colorado Blood Cancer Institute Denver, Colorado, United States
- BRCR Global - Coral Springs Coral Springs, Florida, United States
- START Midwest, LLC Grand Rapids, Michigan, United States
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Trials Office Philadelphia, Pennsylvania, United States
NCT07590986
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +11 more
- Locations
-
- de Duve Institute, UCLouvain Brussels, Woluwe, Belgium
NCT07362225
- Conditions
- Accelerated Phase MPN, Accelerated Phase Myeloproliferative Neoplasm, Agnogenic Myeloid Metaplasia, +78 more
- Locations
-
- MPN Research Foundation Chicago, Illinois, United States
- Memorial Sloan Kettering Cancer Center New York, United States
NCT06770842
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Department of Medicine, Queen Mary Hospital Hong Kong
NCT07319026
- Conditions
- Bone Marrow Diseases, Healthy Subjects, Hematologic Diseases, +7 more
- Locations
-
- Fondazione IRCCS Policlinico San Matteo di Pavia Pavia, Italy
Bomedemstat (IMG-7289/MK-3543) in Participants With Myelofibrosis (IMG-7289-CTP-102/MK-3543-002)
NCT03136185
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
- Locations
-
- University of Michigan Ann Arbor, Michigan, United States
- Royal Adelaide Hospital Adelaide, South Australia, Australia
- Universitatsklinikum Essen Essen, Germany
- Azienda Ospedaliero Universitaria Careggi Florence, Italy
NCT02515630
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Phoenix, Arizona, United States
- Los Angeles, California, United States
- Orange, California, United States
- Jacksonville, Florida, United States
NCT02101268
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Los Angeles, California, United States
- Gainesville, Florida, United States
- Atlanta, Georgia, United States
- Kansas City, Kansas, United States
NCT04217993
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- The First Affiliated Hospital of Medical School of Zhejiang University Hangzhou, Zhejiang, China
NCT00910728
- Conditions
- Bone Marrow Diseases, Essential Thrombocythaemia Myelofibrosis, Hematologic Diseases, +5 more
- Locations
-
- Research Site New York, United States
- Research Site Houston, Texas, United States
- Research Site Villejuif, France
NCT01558739
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +11 more
- Locations
-
- Novartis Investigative Site Cardiff, Wales, United Kingdom
- Novartis Investigative Site Bournemouth, United Kingdom
- Novartis Investigative Site East Yorkshire, United Kingdom
- Novartis Investigative Site Edinburgh, United Kingdom
Extended Access of Momelotinib in Adults With Myelofibrosis
NCT03441113
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
- Locations
-
- GSK Investigational Site Scottsdale, Arizona, United States
- GSK Investigational Site Orange, California, United States
- GSK Investigational Site Stanford, California, United States
- GSK Investigational Site Aurora, Colorado, United States